It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ME’s FA Score shows that 1 FA rating(s) are green whileOM’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ME’s TA Score shows that 4 TA indicator(s) are bullish while OM’s TA Score has 3 bullish TA indicator(s).
ME (@Medical Specialties) experienced а -2.16% price change this week, while OM (@Medical Specialties) price change was +11.88% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +0.94%. For the same industry, the average monthly price growth was +1.17%, and the average quarterly price growth was +2.66%.
ME is expected to report earnings on Feb 05, 2025.
OM is expected to report earnings on Feb 18, 2025.
Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
ME | OM | ME / OM | |
Capitalization | 254M | 112M | 227% |
EBITDA | -299.8M | -153.79M | 195% |
Gain YTD | -82.649 | -79.113 | 104% |
P/E Ratio | N/A | N/A | - |
Revenue | 248M | 130M | 191% |
Total Cash | 242M | 203M | 119% |
Total Debt | 78.8M | 136M | 58% |
ME | OM | |
---|---|---|
RSI ODDS (%) | 1 day ago68% | 1 day ago83% |
Stochastic ODDS (%) | 1 day ago70% | 1 day ago79% |
Momentum ODDS (%) | 1 day ago86% | 1 day ago90% |
MACD ODDS (%) | 1 day ago76% | 1 day ago85% |
TrendWeek ODDS (%) | 1 day ago87% | 1 day ago81% |
TrendMonth ODDS (%) | 1 day ago86% | 1 day ago81% |
Advances ODDS (%) | 19 days ago76% | 5 days ago84% |
Declines ODDS (%) | 1 day ago87% | 1 day ago86% |
BollingerBands ODDS (%) | 1 day ago86% | 1 day ago90% |
Aroon ODDS (%) | 2 days ago85% | 1 day ago76% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
THBVX | 8.14 | 0.07 | +0.87% |
Victory THB US Small Opportunities A | |||
VVPSX | 11.89 | 0.07 | +0.59% |
Vulcan Value Partners Small Cap | |||
HFQTX | 6.03 | 0.03 | +0.50% |
Janus Henderson Global Equity Income T | |||
DRTHX | 19.34 | N/A | N/A |
BNY Mellon Sustainable US Eq Fd Z | |||
FPHAX | 25.98 | -0.10 | -0.38% |
Fidelity Select Pharmaceuticals Port |